CVDs
Recent Insights
Related Topics
Research Articles
Published research studies are articles that present the findings of original research that has undergone a peer-review process and has been made publicly available in scholarly journals, books or other media.
How to submit an article:
- Registered users can submit any published journal article that has a unique DOI (Digital Object Identifier) name or link to Research Hub.
- For example, you can paste the full DOI link:
https://doi.org/10.1109/5.771073
or just the DOI name:10.1109/5.771073
into the field above and click submit. - The person who is first to submit a valid article to Research Hub will forever be credited for it, and every article submission earns you +6 Research Points.
Material basis and integrative pharmacology of danshen decoction in the treatment of cardiovascular diseases
2023 Jan Phytomedicine Liu M, Li Z, Ouyang Y, Chen M, Guo X, Mazhar M, et al.
Danshen Decoction (DSD) plays a role in the treatment of cardiovascular diseases (CVDs) through a variety of active ingredients.
Network Pharmacology Dan Shen DecoctionBeneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021
2021 Jul 15 Nutrients Djuricic I, Calder PC
Higher intakes of omega-3 PUFAs, particularly EPA and DHA, are associated with a lower incidence of chronic diseases characterized by elevated inflammation, including CVDs, and intervention trials using EPA + DHA indicate a benefit on CVD mortality.
Cohort Study Systematic Review Inflammation Omega-3 Fatty Acids Cardiovascular Disease Oxidative StressGastrodia elata Blume (Tianma): Hope for Brain Aging and Dementia
2020 Dec 27 Evidence-Based Complementary and Alternative Medicine Heese K
Review Article Alzheimer's DiseaseTian Ma, a traditional Chinese medicine, shows promise as a complementary therapy for aging-related diseases, including Alzheimer's and cerebrocardiovascular diseases.
The effect of concentrated pomegranate juice consumption on risk factors of cardiovascular diseases in women with polycystic ovary syndrome: A randomized controlled trial
2020 Aug 07 Phytotherapy Research Abedini M, Ghasemi‐Tehrani H, Tarrahi MJ, Amani R
Randomised Controlled Trial Cardiovascular Disease Pomegranate PCOSConcentrated pomegranate juice consumption can potentially lower cardiovascular disease risk factors in women with polycystic ovary syndrome.
Acupuncture for the Treatment of Cardiovascular Diseases: A Systematic Review
2019 Apr Journal of Acupuncture and Meridian Studies de Lima Pimentel R, Duque AP, Moreira BR, Rodrigues LF
This article highlighted that acupuncture is an effective viable alternative as a complementary therapy cardiovascular diseases especially for reducing hypertension
Systematic Review High Blood Pressure Cardiovascular DiseaseResearch Insights
Insights are moderated by the Research Hub team and offer an at-a-glance overview of interesting research findings.
Tian Ma, a traditional Chinese medicine, shows promise as a complementary therapy for aging-related diseases, including Alzheimer's and cerebrocardiovascular diseases.
2020 Evidence-Based Complementary and Alternative Medicine Gastrodia elata Blume (Tianma): Hope for Brain Aging and Dementia Heese K
Review Article Alzheimer's Disease
This study utilized previous research to methodically analyze the efficacy and safety of Tian Ma in treating aging-related diseases. Investigations spanned across various well-structured disease models, with particularly close attention paid to Alzheimer's Disease. The study trialed not just on its raw form, but also explored how it performs within different herbal preparations and as pure natural extracts.
The study's findings indicate that Tian Ma might present a viable alternative treatment for aging-related cerebrocardiovascular diseases and dementia. Specifically, its promising attributes were most noticeable in the context of complementary therapy for Alzheimer's Disease. The potential effectiveness of Tian Ma seems to be maintained across the various preparations, whether in herbal mixtures or as a pure natural product. The study thus concludes on a hopeful note regarding the use of Tian Ma in combatting debilitating age-linked conditions.
Concentrated pomegranate juice consumption can potentially lower cardiovascular disease risk factors in women with polycystic ovary syndrome.
2020 Phytotherapy Research The effect of concentrated pomegranate juice consumption on risk factors of cardiovascular diseases in women with polycystic ovary syndrome: A randomized controlled trial Abedini M, Ghasemi‐Tehrani H, Tarrahi MJ, Amani R
Randomised Controlled Trial Cardiovascular Disease PCOS Pomegranate
The study used a randomized clinical approach, enrolling 44 women identified with polycystic ovary syndrome, aged 18 to 40 years and above a certain body weight index. These participants were randomly divided into two groups: one group was given concentrated pomegranate juice (CPJ), while the other served as a control. Both groups were monitored over a period of 8 weeks, with baseline measurements taken for anthropometric measures, blood pressure, and biochemical parameters set at the onset and then compared at the end of the trial.
Upon completion, the group that consumed CPJ showed reductions in blood pressure and serum triglyceride levels — a known risk factor for cardiovascular diseases. There was also an increase in the amount of high density lipoprotein-cholesterol (good cholesterol) and a decrease in the triglyceride to high-density lipoprotein-cholesterol ratio. However, an increase was observed in levels of low-density lipoprotein-cholesterol (bad cholesterol). No adverse events or complications arose from CPJ consumption during the study period.
Review Articles
Review articles summarise and critically evaluate the current state of research on a specific topic or field by synthesising multiple primary research studies.
Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021
2021 Jul 15 Nutrients Djuricic I, Calder PC
Higher intakes of omega-3 PUFAs, particularly EPA and DHA, are associated with a lower incidence of chronic diseases characterized by elevated inflammation, including CVDs, and intervention trials using EPA + DHA indicate a benefit on CVD mortality.
Cohort Study Systematic Review Inflammation Omega-3 Fatty Acids Cardiovascular Disease Oxidative StressGastrodia elata Blume (Tianma): Hope for Brain Aging and Dementia
2020 Dec 27 Evidence-Based Complementary and Alternative Medicine Heese K
Review Article Alzheimer's DiseaseTian Ma, a traditional Chinese medicine, shows promise as a complementary therapy for aging-related diseases, including Alzheimer's and cerebrocardiovascular diseases.
Acupuncture for the Treatment of Cardiovascular Diseases: A Systematic Review
2019 Apr Journal of Acupuncture and Meridian Studies de Lima Pimentel R, Duque AP, Moreira BR, Rodrigues LF
This article highlighted that acupuncture is an effective viable alternative as a complementary therapy cardiovascular diseases especially for reducing hypertension
Systematic Review High Blood Pressure Cardiovascular DiseaseTherapeutic Effects of Wenxin Keli in Cardiovascular Diseases: An Experimental and Mechanism Overview
2018 Sep 05 Frontiers in Pharmacology Tian G, Sun Y, Liu S, Li C, Chen S, Qiu R, et al.
Wenxin Keli has been observed to have multiple positive functions in cardiovascular diseases (CVDs), including myocardial protection and anti-arrhythmia. Wenxin Keli (WXKL) played its cardioprotective roles by inhibiting inflammatory reaction, decreasing oxidative stress, regulating vasomotor disorders, lowering cell apoptosis, and protection against endothelial injure, myocardial ischemia, cardiac fibrosis, and cardiac hypertrophy.
Review Article Wen Xin Ke Li Cardiovascular DiseaseRhizoma Coptidis: A Potential Cardiovascular Protective Agent
2016 Oct 07 Frontiers in Pharmacology Tan HL, Chan KG, Pusparajah P, Duangjai A, Saokaew S, Mehmood Khan T, et al.
In conclusion, results of recent studies appear to support for the usage of RC for treatment of CVDs and related conditions. RC appears to have tremendous potential as a cardioprotective agent given its ability to improve a large number of parameters associated with increased risk of CVDs including anti-atherosclerotic effect, lipid-lowering effect, anti-obesity effect and anti-hepatic steatosis effect. Aside from reducing incidence, it also reduces the damage caused by CVDs as it confers protection from myocardial I/R injury. However, knowledge regarding the underlying mechanisms of action of these compounds is still limited. More research investigating the exact mechanisms of RC's cardioprotective activities is needed.
Review Article Huang Lian Cardiovascular DiseaseClinical Trials
Clinical trials are research studies that involve people and are conducted to evaluate the safety and efficacy of new treatments or interventions, such as drugs, medical devices, or behavioural therapies.
Study Protocols
Published study protocols are detailed plans that outline the objectives, methodology, statistical analyses, and organisation of a research study that have been made publicly available for others to review and use as a reference.
Presentation Slides
Review Article
Tian Ma, a traditional Chinese medicine, shows promise as a complementary therapy for aging-related diseases, including Alzheimer's and cerebrocardiovascular diseases.
Heese K
Randomised Controlled Trial
Concentrated pomegranate juice consumption can potentially lower cardiovascular disease risk factors in women with polycystic ovary syndrome.
Abedini M, Ghasemi‐Tehrani H, Tarrahi MJ, Amani R
Executive Summary
Write an executive summary in the form of a blog article on the topic of "Research into Chinese medicine treatment for CVDs" summarising the research below and using language that can be easily understood by patients and avoiding medical jargon using a professional and caring tone of voice.
Write an executive summary in the form of a blog article on the topic of "Researched Chinese medicine treatments for CVDs" summarising the research below in an objective and easy to understand way, and using language that can be easily understood by patients. Group the article into Chinese medicine treatments first, followed by nutrition and other treatments. Avoid using medical jargon and use a professional and caring tone of voice.
Write me a concise but easy to understand executive summary on the topic of "Chinese medicine treatments for CVDs" based on the following research that I will give you. Your summary should be 2 paragraphs long in Australian English spelling and include references to the studies.
A Review Article published in 2020 in the journal Evidence-Based Complementary and Alternative Medicine found that Tian Ma, a traditional Chinese medicine, shows promise as a complementary therapy for aging-related diseases, including Alzheimer's and cerebrocardiovascular diseases. This study utilized previous research to methodically analyze the efficacy and safety of Tian Ma in treating aging-related diseases. Investigations spanned across various well-structured disease models, with particularly close attention paid to Alzheimer's Disease. The study trialed not just on its raw form, but also explored how it performs within different herbal preparations and as pure natural extracts. The study's findings indicate that Tian Ma might present a viable alternative treatment for aging-related cerebrocardiovascular diseases and dementia. Specifically, its promising attributes were most noticeable in the context of complementary therapy for Alzheimer's Disease. The potential effectiveness of Tian Ma seems to be maintained across the various preparations, whether in herbal mixtures or as a pure natural product. The study thus concludes on a hopeful note regarding the use of Tian Ma in combatting debilitating age-linked conditions.
A Randomised Controlled Trial published in 2020 in the journal Phytotherapy Research found that Concentrated pomegranate juice consumption can potentially lower cardiovascular disease risk factors in women with polycystic ovary syndrome. The study used a randomized clinical approach, enrolling 44 women identified with polycystic ovary syndrome, aged 18 to 40 years and above a certain body weight index. These participants were randomly divided into two groups: one group was given concentrated pomegranate juice (CPJ), while the other served as a control. Both groups were monitored over a period of 8 weeks, with baseline measurements taken for anthropometric measures, blood pressure, and biochemical parameters set at the onset and then compared at the end of the trial. Upon completion, the group that consumed CPJ showed reductions in blood pressure and serum triglyceride levels — a known risk factor for cardiovascular diseases. There was also an increase in the amount of high density lipoprotein-cholesterol (good cholesterol) and a decrease in the triglyceride to high-density lipoprotein-cholesterol ratio. However, an increase was observed in levels of low-density lipoprotein-cholesterol (bad cholesterol). No adverse events or complications arose from CPJ consumption during the study period.
Moderation Tools
Topic
Sign In
Users not signed in are limited to viewing the 5 most recent items of content.